Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,605-8,616 of 23,847
Behavioral study icon
Enrolling By InvitationNCT05814653

Primary Care Treatment for Eating disorders

This study is enrolling by invitation in the United States. It is testing primary Care Treatment for Eating disorders.

In Rochester
Eating disordersBehavioralFrom 7 Years to 18 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Eating disorders
Behavioral study icon
CompletedNCT05686239

RL-007 for schizophrenia

This study is completed in the United States, in Bulgaria, in Czechia, .... It is testing RL-007 for schizophrenia.

Multiple locations, including Culver City
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Recognify Life Sciences
Condition
Schizophrenia
Drug study icon
CompletedNCT05443724

Safety study of CVL-231 (Emraclidine) in schizophrenia

This study is completed in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.

Multiple locations, including Phoenix
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Hungary, ...
Sponsor
AbbVie
Condition
Schizophrenia
Drug study icon
CompletedNCT02614547

SAGE-547 in people with Severe Postpartum Depression

This study is completed in the United States. It is testing SAGE-547 for depression.

Multiple locations, including Atlanta
DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.